DUPLICATION OF THE SOX3 GENE IN AN SRY-NEGATIVE
46,XX MALE WITH ASSOCIATED CONGENITAL ANOMALIES
OF KIDNEYS AND THE URINARY TRACT:
CASE REPORT AND REVIEW OF THE LITERATURE
Tasic V1, Mitrotti A2, Riepe FG3, Kulle AE3, Laban N1, Polenakovic M4,
Plaseska-Karanfilska D4, Sanna-Cherchi S2, Kostovski M1, Gucev Z1,*
*Corresponding Author: Professor Dr. Zoran Gucev, University Children’s Hospital, Medical Faculty
Skopje, ul. Majka Tereza 17, 1000 Skopje, Republic of Macedonia. Mobile: +389-70-279-742.
E-mail: gucevz@ gmail.com
page: 81
|
|
REFERENCES
1. Blackless M, Charuvastra A, Derryck A, Fausto-Sterling
A, Lauzanne K, Lee E. How sexually dimorphic
are we? Review and synthesis. Am J Hum Biol. 2000;
12(2): 151-66.
2. Springer A, van den Heijkant M, Baumann S. Worldwide
prevalence of hypospadias. J Pediatr Urol. 2016;
12(3): 152e1-e7.
3. Hughes IA, Nihoul-Fekete C, Thomas B, Cohen-
Kettenis PT. Consequences of the ESPE/LWPES
guidelines for diagnosis and treatment of disorders
of sex development. Best Pract Res Clin Endocrinol
Metab. 2007; 21(3): 351-365.
4. de la Chapelle A. The etiology of maleness in XX
men. Hum Genet. 1981; 58(1): 105-116.
5. Johnson JA, Aughton DJ, Comstock CH, von Oeyen
PT, Higgins JV, Schulz R. Prenatal diagnosis of
Smith-Lemli-Opitz syndrome, type II. Am J Med
Genet. 1994; 49(2): 240-243.
6. Rutledge JC, Friedman JM, Harrod, MJ, Currarino G,
Wright CG, Pinckney L, et al. A “new” lethal multiple
congenital anomaly syndrome: Joint contractures, cerebellar
hypoplasia, renal hypoplasia, urogenital anomalies,
tongue cysts, shortness of limbs, eye abnormalities,
defects of the heart, gallbladder agenesis, and ear
malformations. Am J Med Genet. 1984; 19(2): 255-64.
7. Patek CE, Little MH, Fleming S, Miles C, Charlieu
JP, Clarke AR, et al. A zinc finger truncation of
murine WT1 results in the characteristic urogenital
abnormalities of Denys-Drash syndrome. Proc Natl
Acad Sci USA. 1999; 96(6): 2931-2936.
8. Berta P, Morin D, Poulat F, Taviaux S, Lobaccaro
JM, Sultan C, et al. Molecular analysis of the sexdetermining
region from the Y chromosome in two
patients with Frasier syndrome. Horm Res. 1992;
37(3): 103-106.
9. Narahara K, Kikkawa K, Kimira S, Kimoto H, Ogata
M, Kasai R, et al. Regional mapping of catalase and
Wilms tumor--aniridia, genitourinary abnormalities,
and mental retardation triad loci to the chromosome
segment 11p1305----p1306. Hum Genet. 1984; 66(2-
3): 181-185.
10. vanHeyningen V, Bickmore WA, Seawright A, Fletcher
JM, Maule J, Fekete G, et al. Role for the Wilms
tumor gene in genital development? ProcNatl Acad
Sci USA. 1990; 87(14): 5383-5386.
11. Waters PD, Wallis MC, Marshall Graves JA. Mammalian
sex--Origin and evolution of the Y chromosome
and SRY. Semin Cell Dev Biol. 2007; 18(3):
389-400.
12. Sekido R, Lovell-Badge R. Sex determination involves
synergistic action of SRY and SF1 on a specific
Sox9 enhancer. Nature. 2008; 453(7197): 930-934.
13. Sekido R, Bar I, Narvaez V, Penny G, Lovell-Badge
R. SOX9 is up-regulated by the transient expression
of SRY specifically in Sertoli cell precursors. Dev
Biol. 2004; 274(2): 271-279.
14. Palmer SJ, Burgoyne PS. In situ analysis of fetal, prepuberal
and adult XX----XY chimaeric mouse testes:
Sertoli cells are predominantly, but not exclusively,
XY. Development. 1991; 112(1): 265-268.
15. Stevanovic M, Lovell-Badge R, Collignon J, Goodfellow
PN. SOX3 is an X-linked gene related to SRY.
Hum Mol Genet. 1993; 2(12): 2013-2018.
16. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji
M, Norris D, Rastan S, et al. A comparison
of the properties of Sox-3 with Sry and two related
genes, Sox-1 and Sox-2. Development. 1996; 122(2):
509-520.
17. Laumonnier F, Ronce N, Hamel BC, Thomas P,
Lespinasse J, Raynaud M, et al. Transcription factor
SOX3 is involved in X-linked mental retardation with
growth hormone deficiency. Am J Hum Genet. 2002;
71(6): 1450-1455.
18. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A,
Palmer R, et al. Over- and underdosage of SOX3 is
associated with infundibular hypoplasia and hypopituitarism.
Am J Hum Genet. 2005; 76(5): 833-849. 19. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ,
Robinson IC, Lovell-Badge R. SOX3 is required during
the formation of the hypothalamo-pituitary axis.
Nat Genet. 2004; 36(3): 247-255.
20. Dee CT, Hirst CS, Shih YH, Tripathi VB, Patient
RK, Scotting PJ. Sox3 regulates both neural fate and
differentiation in the zebrafish ectoderm. Dev Biol.
2008; 320(1): 289-301.
21. Bylund M, Andersson E, Novitch BG, Muhr J. Vertebrate
neurogenesis is counteracted by Sox1-3 activity.
Nat Neurosci. 2003; 6(11): 1162-1168.
22. Rizzoti K, Lovell-Badge R. SOX3 activity during pharyngeal
segmentation is required for craniofacial morphogenesis.
Development. 2007; 134(19): 3437-3448.
23. des Portes V, Carrie A, Billuart P, Kieffer V, Bienvenu
T, Vinet MC, et al. Inherited microdeletion in Xp21.3-
22.1 involved in non-specific mental retardation. Clin
Genet. 1998; 53(2): 136-141.
24. Carrie A, Jun L, Bienvenu T, Vinet MC, McDonell
N, Couvert P, et al. A new member of the IL-1 receptor
family highly expressed in hippocampus and
involved in X-linked mental retardation. Nat Genet.
1999; 23(1): 25-31.
25. Solomon NM, Ross SA, Morgan T, Belsky JL, Hol
FA, Karnes PS, et al. Array comparative genomic
hybridisation analysis of boys with X linked hypopituitarism
identifies a 3.9 Mb duplicated critical region
at Xq27 containing SOX3. J Med Genet. 2004; 41(9):
669-678.
26. Sutton E, Hughes J, White S, Sekido R, Tan J, Arboleda
V, et al. Identification of SOX3 as an XX male
sex reversal gene in mice and humans. J Clin Invest.
2011; 121(1): 328-341.
27. Grinspon RP, Nevado J, Mori Alvarez Mde L, Del Rey
G, Castera R, Venara M, et al. 46,XX ovotesticular
DSD associated with a SOX3 gene duplication in
a SRY-negative boy. Clin Endocrinol (Oxf). 2016;
85(4): 673-675.
28. Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M,
Sampson MG, Hadley D, et al. Copy-number disorders
are a common cause of congenital kidney malformations.
Am J Hum Genet. 2012; 91(6): 987-997.
29. Kulle AE, Riepe FG, Melchior D, Hiort O, Holterhus
PM. A novel ultrapressure liquid chromatography tandem
mass spectrometry method for the simultaneous
determination of androstenedione, testosterone, and
dihydro-testosterone in pediatric blood samples: Ageand
sex-specific reference data. J Clin Endocrinol
Metab. 2010; 95(5): 2399-2409.
30. Kulle AE, Welzel M, Holterhus PM, Riepe FG. Implementation
of a liquid chromatography tandem mass
spectrometry assay for eight adrenal C-21 steroids
and pediatric reference data. Horm Res Paediatr.
2013; 79(1): 22-31.
31. Kulle AE, Riepe FG, Hedderich J, Sippell WG,
Schmitz J, Niermeyer L, et al. LC-MS/MS based
determination of basal- and ACTH-stimulated plasma
concentrations of 11 steroid hormones: Implications
for detecting heterozygote CYP21A2 mutation carriers.
Eur J Endocrinol. 2015; 173(4): 517-524.
32. Padmanabhan S, Melander O, Johnson T, Di Blasio
AM, Lee WK, Gentilini D, et al. Genome-wide association
study of blood pressure extremes identifies
variant near UMOD associated with hypertension.
PLoS Genet. 2010; 6(10): e1001177.
33. Verbitsky M, Sanna-Cherchi S, Fasel DA, Levy B,
Kiryluk K, Wuttke M, et al. Genomic imbalances in
pediatric patients with chronic kidney disease. J Clin
Invest. 2015; 125(5): 2171-2178.
34. Westland R, Verbitsky M, Vukojevic K, Perry BJ, Fasel
DA, Zwijnenburg PJ, et al. Copy number variation
analysis identifies novel CAKUT candidate genes in
children with a solitary functioning kidney. Kidney
Int. 2015; 88(6): 1402-1410.
35. Lopez-Rivera E, Liu YP, Verbitsky M, Anderson BR,
Capone VP, Otto EA, et al. Genetic drivers of kidney
defects in the DiGeorge syndrome. N Engl J Med.
2017; 376(8): 742-754.
36. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira
MA, Bender D, et al. PLINK: A tool set for
whole-genome association and population-based
linkage analyses. Am J Hum Genet. 2007; 81(3):
559-575.
37. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF,
et al. PennCNV: An integrated hidden Markov model
designed for high-resolution copy number variation
detection in whole-genome SNP genotyping data.
Genome Res. 2007; 17(11): 1665-1674.
38. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha
MT, Moreno-De-Luca D, et al. Multiple recurrent
de novo CNVs, including duplications of the 7q11.23
Williams syndrome region, are strongly associated
with autism. Neuron. 2011; 70(5): 863-885. 39. Lagerstrom-Fermer M, Sundvall M, Johnsen E,
Warne GL, Forrest SM, Zajac JD, et al. X-linked
recessive panhypopituitarism associated with a regional
duplication in Xq25-q26. Am J Hum Genet.
1997; 60(4): 910-916. 40. Hamel BC, Smits AP, Otten BJ, van den Helm B,
Ropers HH, Mariman EC. Familial X-linked mental
retardation and isolated growth hormone deficiency:
Clinical and molecular findings. Am J Med Genet.
1996; 64(1): 35-41.
41. Gucev Z, Tasic V, Plaseska-Karanfilska D, Konstantinova
MK, Stamatova A, Dimishkovska M, et
al. LHX4 gene alterations: Patient report and review
of the literature. Pediatr Endocrinol Rev. 2016; 13(4):
749-755.
42. Mojsin M, Stevanovic M. PBX1 and MEIS1 up-regulate
SOX3 gene expression by direct interaction with
a consensus binding site within the basal promoter
region. Biochem J. 2009; 425(1): 107-116.
43. Schnabel CA, Godin RE, Cleary ML. Pbx1 regulates
nephrogenesis and ureteric branching in the developing
kidney. Dev Biol. 2003; 254(2): 262-276.
44. Le Tanno P, Breton J, Bidart M, Satre V, Harbuz R,
Ray PF, et al. PBX1 haploinsufficiency leads to syndromic
congenital anomalies of the kidney and urinary
tract (CAKUT) in humans. J Med Genet. 2017;
54(7): 502-510.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
